Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 3. The proportion of patients those achieved 2 or less in Frequency, Intensity, and Burden of Side Effects Ratings sub-scores at the end of treatment.

PGATx, pharmacogenomic-based antidepressant treatment; TAU, treatment as usual.

Clinical Psychopharmacology and Neuroscience 2018;16:469~480
© Clin Psychopharmacol Neurosci